Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 143 entries
Sorted by: Best Match Show Resources per page
Metrology of nanoscale grating structures by UV scatterometry.

Optics express

Wurm M, Endres J, Probst J, Schoengen M, Diener A, Bodermann B.
PMID: 29519091
Opt Express. 2017 Feb 06;25(3):2460-2468. doi: 10.1364/OE.25.002460.

In this contribution we demonstrate goniometric scatterometry measurements of gratings with linewidths down to 25 nm on silicon wafers with an inspection wavelength of 266 nm. For each sample, measurements have been performed in four different configurations and the...

Cite
Wurm M, Endres J, Probst J, et al. Metrology of nanoscale grating structures by UV scatterometry. Opt Express. 2017;25(3):2460-2468doi: 10.1364/OE.25.002460.
Wurm, M., Endres, J., Probst, J., Schoengen, M., Diener, A., & Bodermann, B. (2017). Metrology of nanoscale grating structures by UV scatterometry. Optics express, 25(3), 2460-2468. https://doi.org/10.1364/OE.25.002460
Wurm, Matthias, et al. "Metrology of nanoscale grating structures by UV scatterometry." Optics express vol. 25,3 (2017): 2460-2468. doi: https://doi.org/10.1364/OE.25.002460
Wurm M, Endres J, Probst J, Schoengen M, Diener A, Bodermann B. Metrology of nanoscale grating structures by UV scatterometry. Opt Express. 2017 Feb 06;25(3):2460-2468. doi: 10.1364/OE.25.002460. PMID: 29519091.
Copy Download .nbib Format: NLM
Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry.

PloS one

Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mérida MR, Ptáček LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ.
PMID: 26322789
PLoS One. 2015 Aug 31;10(8):e0137370. doi: 10.1371/journal.pone.0137370. eCollection 2015.

No abstract available.

Cite
Viollet L, Glusman G, Murphy KJ, et al. Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PLoS One. 2015;10(8):e0137370doi: 10.1371/journal.pone.0137370.
Viollet, L., Glusman, G., Murphy, K. J., Newcomb, T. M., Reyna, S. P., Sweney, M., Nelson, B., Andermann, F., Andermann, E., Acsadi, G., Barbano, R. L., Brown, C., Brunkow, M. E., Chugani, H. T., Cheyette, S. R., Collins, A., DeBrosse, S. D., Galas, D., Friedman, J., Hood, L., Huff, C., Jorde, L. B., King, M. D., LaSalle, B., Leventer, R. J., Lewelt, A. J., Massart, M. B., Mérida, M. R., Ptáček, L. J., Roach, J. C., Rust, R. S., Renault, F., Sanger, T. D., Sotero de Menezes, M. A., Tennyson, R., Uldall, P., Zhang, Y., Zupanc, M., Xin, W., Silver, K., & Swoboda, K. J. (2015). Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PloS one, 10(8), e0137370. https://doi.org/10.1371/journal.pone.0137370
Viollet, Louis, et al. "Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry." PloS one vol. 10,8 (2015): e0137370. doi: https://doi.org/10.1371/journal.pone.0137370
Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mérida MR, Ptáček LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ. Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PLoS One. 2015 Aug 31;10(8):e0137370. doi: 10.1371/journal.pone.0137370. eCollection 2015. PMID: 26322789; PMCID: PMC4554723.
Copy Download .nbib Format: NLM
Severe Amnesia in Epilepsy: Causes, Anatomopsychological Considerations, and Treatment.

Epilepsy & behavior : E&B

Guerreiro CA, Jones-Gotman M, Andermann F, Bastos A, Cendes F.
PMID: 12609367
Epilepsy Behav. 2001 Jun;2(3):224-246. doi: 10.1006/ebeh.2001.0167.

Severe amnesia in epileptic patients is a catastrophic condition that may be due to different etiologies. Because of the striking findings and thorough neuropsychological studies of Patient H.M., the literature has focused on postsurgical occurrence of such memory impairment,...

Cite
Guerreiro CA, Jones-Gotman M, Andermann F, et al. Severe Amnesia in Epilepsy: Causes, Anatomopsychological Considerations, and Treatment. Epilepsy Behav. 2001;2(3):224-246doi: 10.1006/ebeh.2001.0167.
Guerreiro, C. A., Jones-Gotman, M., Andermann, F., Bastos, A., & Cendes, F. (2001). Severe Amnesia in Epilepsy: Causes, Anatomopsychological Considerations, and Treatment. Epilepsy & behavior : E&B, 2(3), 224-246. https://doi.org/10.1006/ebeh.2001.0167
Guerreiro, Carlos A. M., et al. "Severe Amnesia in Epilepsy: Causes, Anatomopsychological Considerations, and Treatment." Epilepsy & behavior : E&B vol. 2,3 (2001): 224-246. doi: https://doi.org/10.1006/ebeh.2001.0167
Guerreiro CA, Jones-Gotman M, Andermann F, Bastos A, Cendes F. Severe Amnesia in Epilepsy: Causes, Anatomopsychological Considerations, and Treatment. Epilepsy Behav. 2001 Jun;2(3):224-246. doi: 10.1006/ebeh.2001.0167. PMID: 12609367.
Copy Download .nbib Format: NLM
Breaking away from the disease-focused paradigm.

Lancet (London, England)

Andermann A.
PMID: 21168051
Lancet. 2010 Dec 18;376(9758):2073-4. doi: 10.1016/S0140-6736(10)62294-5.

No abstract available.

Cite
Andermann A. Breaking away from the disease-focused paradigm. Lancet. 2010;376(9758):2073-4doi: 10.1016/S0140-6736(10)62294-5.
Andermann, A. (2010). Breaking away from the disease-focused paradigm. Lancet (London, England), 376(9758), 2073-4. https://doi.org/10.1016/S0140-6736(10)62294-5
Andermann, Anne. "Breaking away from the disease-focused paradigm." Lancet (London, England) vol. 376,9758 (2010): 2073-4. doi: https://doi.org/10.1016/S0140-6736(10)62294-5
Andermann A. Breaking away from the disease-focused paradigm. Lancet. 2010 Dec 18;376(9758):2073-4. doi: 10.1016/S0140-6736(10)62294-5. PMID: 21168051.
Copy Download .nbib Format: NLM
Outbreaks in the age of syndemics: New insights for improving Indigenous health.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Andermann A.
PMID: 29770077
Can Commun Dis Rep. 2017 Jun 01;43(6):125-132. doi: 10.14745/ccdr.v43i06a02. eCollection 2017 Jun 01.

Conventional approaches for the prevention and control of communicable diseases within Indigenous contexts may benefit from new insights arising from the growing interest in syndemics. Syndemics is a term used to describe a conceptual framework for understanding diseases or...

Cite
Andermann A. Outbreaks in the age of syndemics: New insights for improving Indigenous health. Can Commun Dis Rep. 2017;43(6):125-132doi: 10.14745/ccdr.v43i06a02.
Andermann, A. (2017). Outbreaks in the age of syndemics: New insights for improving Indigenous health. Canada communicable disease report = Releve des maladies transmissibles au Canada, 43(6), 125-132. https://doi.org/10.14745/ccdr.v43i06a02
Andermann, A. "Outbreaks in the age of syndemics: New insights for improving Indigenous health." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 43,6 (2017): 125-132. doi: https://doi.org/10.14745/ccdr.v43i06a02
Andermann A. Outbreaks in the age of syndemics: New insights for improving Indigenous health. Can Commun Dis Rep. 2017 Jun 01;43(6):125-132. doi: 10.14745/ccdr.v43i06a02. eCollection 2017 Jun 01. PMID: 29770077; PMCID: PMC5764735.
Copy Download .nbib Format: NLM
Individual differences in change blindness are predicted by the strength and stability of visual representations.

Neuroscience of consciousness

Andermane N, Bosten JM, Seth AK, Ward J.
PMID: 30697440
Neurosci Conscious. 2019 Jan 24;2019(1):niy010. doi: 10.1093/nc/niy010. eCollection 2019.

The phenomenon of change blindness reveals that people are surprisingly poor at detecting unexpected visual changes; however, research on individual differences in detection ability is scarce. Predictive processing accounts of visual perception suggest that better change detection may be...

Cite
Andermane N, Bosten JM, Seth AK, et al. Individual differences in change blindness are predicted by the strength and stability of visual representations. Neurosci Conscious. 2019;2019(1):niy010doi: 10.1093/nc/niy010.
Andermane, N., Bosten, J. M., Seth, A. K., & Ward, J. (2019). Individual differences in change blindness are predicted by the strength and stability of visual representations. Neuroscience of consciousness, 2019(1), niy010. https://doi.org/10.1093/nc/niy010
Andermane, Nora, et al. "Individual differences in change blindness are predicted by the strength and stability of visual representations." Neuroscience of consciousness vol. 2019,1 (2019): niy010. doi: https://doi.org/10.1093/nc/niy010
Andermane N, Bosten JM, Seth AK, Ward J. Individual differences in change blindness are predicted by the strength and stability of visual representations. Neurosci Conscious. 2019 Jan 24;2019(1):niy010. doi: 10.1093/nc/niy010. eCollection 2019. PMID: 30697440; PMCID: PMC6345093.
Copy Download .nbib Format: NLM
A Guide to Carrying Out a Phylogenomic Target Sequence Capture Project.

Frontiers in genetics

Andermann T, Torres Jiménez MF, Matos-Maraví P, Batista R, Blanco-Pastor JL, Gustafsson ALS, Kistler L, Liberal IM, Oxelman B, Bacon CD, Antonelli A.
PMID: 32153629
Front Genet. 2020 Feb 21;10:1407. doi: 10.3389/fgene.2019.01407. eCollection 2019.

High-throughput DNA sequencing techniques enable time- and cost-effective sequencing of large portions of the genome. Instead of sequencing and annotating whole genomes, many phylogenetic studies focus sequencing effort on large sets of pre-selected loci, which further reduces costs and...

Cite
Andermann T, Torres Jiménez MF, Matos-Maraví P, et al. A Guide to Carrying Out a Phylogenomic Target Sequence Capture Project. Front Genet. 2020;10:1407doi: 10.3389/fgene.2019.01407.
Andermann, T., Torres Jiménez, M. F., Matos-Maraví, P., Batista, R., Blanco-Pastor, J. L., Gustafsson, A. L. S., Kistler, L., Liberal, I. M., Oxelman, B., Bacon, C. D., & Antonelli, A. (2019). A Guide to Carrying Out a Phylogenomic Target Sequence Capture Project. Frontiers in genetics, 101407. https://doi.org/10.3389/fgene.2019.01407
Andermann, Tobias, et al. "A Guide to Carrying Out a Phylogenomic Target Sequence Capture Project." Frontiers in genetics vol. 10 (2019): 1407. doi: https://doi.org/10.3389/fgene.2019.01407
Andermann T, Torres Jiménez MF, Matos-Maraví P, Batista R, Blanco-Pastor JL, Gustafsson ALS, Kistler L, Liberal IM, Oxelman B, Bacon CD, Antonelli A. A Guide to Carrying Out a Phylogenomic Target Sequence Capture Project. Front Genet. 2020 Feb 21;10:1407. doi: 10.3389/fgene.2019.01407. eCollection 2019. PMID: 32153629; PMCID: PMC7047930.
Copy Download .nbib Format: NLM
Some aspects on the uncertainty calculation in Mueller ellipsometry.

Optics express

Wurm M, Grunewald T, Teichert S, Bodermann B, Reck J, Richter U.
PMID: 32225443
Opt Express. 2020 Mar 16;28(6):8108-8131. doi: 10.1364/OE.381244.

In this paper, we focus on the metrological aspects of spectroscopic Mueller ellipsometry-i.e. on the uncertainty estimation of the measurement results. With the help of simulated Mueller matrices, we demonstrate that the commonly used merit functions do not return...

Cite
Wurm M, Grunewald T, Teichert S, et al. Some aspects on the uncertainty calculation in Mueller ellipsometry. Opt Express. 2020;28(6):8108-8131doi: 10.1364/OE.381244.
Wurm, M., Grunewald, T., Teichert, S., Bodermann, B., Reck, J., & Richter, U. (2020). Some aspects on the uncertainty calculation in Mueller ellipsometry. Optics express, 28(6), 8108-8131. https://doi.org/10.1364/OE.381244
Wurm, Matthias, et al. "Some aspects on the uncertainty calculation in Mueller ellipsometry." Optics express vol. 28,6 (2020): 8108-8131. doi: https://doi.org/10.1364/OE.381244
Wurm M, Grunewald T, Teichert S, Bodermann B, Reck J, Richter U. Some aspects on the uncertainty calculation in Mueller ellipsometry. Opt Express. 2020 Mar 16;28(6):8108-8131. doi: 10.1364/OE.381244. PMID: 32225443.
Copy Download .nbib Format: NLM
A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy.

RNA biology

Martens L, Rühle F, Witten A, Meder B, Katus HA, Arbustini E, Hasenfuß G, Sinner MF, Kääb S, Pankuweit S, Angermann C, Bornberg-Bauer E, Stoll M.
PMID: 34313541
RNA Biol. 2021 Oct 15;18:409-415. doi: 10.1080/15476286.2021.1952756. Epub 2021 Jul 27.

lncRNAs are at the core of many regulatory processes and have also been recognized to be involved in various complex diseases. They affect gene regulation through direct interactions with RNA, DNA or proteins. Accordingly, lncRNA structure is likely to...

Cite
Martens L, Rühle F, Witten A, et al. A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. RNA Biol. 2021;18:409-415doi: 10.1080/15476286.2021.1952756.
Martens, L., Rühle, F., Witten, A., Meder, B., Katus, H. A., Arbustini, E., Hasenfuß, G., Sinner, M. F., Kääb, S., Pankuweit, S., Angermann, C., Bornberg-Bauer, E., & Stoll, M. (2021). A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. RNA biology, 18409-415. https://doi.org/10.1080/15476286.2021.1952756
Martens, Leonie, et al. "A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy." RNA biology vol. 18 (2021): 409-415. doi: https://doi.org/10.1080/15476286.2021.1952756
Martens L, Rühle F, Witten A, Meder B, Katus HA, Arbustini E, Hasenfuß G, Sinner MF, Kääb S, Pankuweit S, Angermann C, Bornberg-Bauer E, Stoll M. A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. RNA Biol. 2021 Oct 15;18:409-415. doi: 10.1080/15476286.2021.1952756. Epub 2021 Jul 27. PMID: 34313541.
Copy Download .nbib Format: NLM
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

European heart journal

, Sammons E, Hopewell JC, Chen F, Stevens W, Wallendszus K, Valdes-Marquez E, Dayanandan R, Knott C, Murphy K, Wincott E, Baxter A, Goodenough R, Lay M, Hill M, Macdonnell S, Fabbri G, Lucci D, Fajardo-Moser M, Brenner S, Hao D, Zhang H, Liu J, Wuhan B, Mosegaard S, Herrington W, Wanner C, Angermann C, Ertl G, Maggioni A, Barter P, Mihaylova B, Mitchel Y, Blaustein R, Goto S, Tobert J, DeLucca P, Chen Y, Chen Z, Gray A, Haynes R, Armitage J, Baigent C, Wiviott S, Cannon C, Braunwald E, Collins R, Bowman L, Landray M.
PMID: 34910136
Eur Heart J. 2021 Dec 15; doi: 10.1093/eurheartj/ehab863. Epub 2021 Dec 15.

AIMS: REVEAL was the first randomized controlled trial to demonstrate that adding cholesteryl ester transfer protein inhibitor therapy to intensive statin therapy reduced the risk of major coronary events. We now report results from extended follow-up beyond the scheduled...

Cite
, Sammons E, Hopewell JC, et al. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab863.
, Sammons, E., Hopewell, J. C., Chen, F., Stevens, W., Wallendszus, K., Valdes-Marquez, E., Dayanandan, R., Knott, C., Murphy, K., Wincott, E., Baxter, A., Goodenough, R., Lay, M., Hill, M., Macdonnell, S., Fabbri, G., Lucci, D., Fajardo-Moser, M., Brenner, S., Hao, D., Zhang, H., Liu, J., Wuhan, B., Mosegaard, S., Herrington, W., Wanner, C., Angermann, C., Ertl, G., Maggioni, A., Barter, P., Mihaylova, B., Mitchel, Y., Blaustein, R., Goto, S., Tobert, J., DeLucca, P., Chen, Y., Chen, Z., Gray, A., Haynes, R., Armitage, J., Baigent, C., Wiviott, S., Cannon, C., Braunwald, E., Collins, R., Bowman, L., Landray, M. (2021). Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. European heart journal, . https://doi.org/10.1093/eurheartj/ehab863
, et al. "Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab863
, Sammons E, Hopewell JC, Chen F, Stevens W, Wallendszus K, Valdes-Marquez E, Dayanandan R, Knott C, Murphy K, Wincott E, Baxter A, Goodenough R, Lay M, Hill M, Macdonnell S, Fabbri G, Lucci D, Fajardo-Moser M, Brenner S, Hao D, Zhang H, Liu J, Wuhan B, Mosegaard S, Herrington W, Wanner C, Angermann C, Ertl G, Maggioni A, Barter P, Mihaylova B, Mitchel Y, Blaustein R, Goto S, Tobert J, DeLucca P, Chen Y, Chen Z, Gray A, Haynes R, Armitage J, Baigent C, Wiviott S, Cannon C, Braunwald E, Collins R, Bowman L, Landray M. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. Eur Heart J. 2021 Dec 15; doi: 10.1093/eurheartj/ehab863. Epub 2021 Dec 15. PMID: 34910136.
Copy Download .nbib Format: NLM
A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.

Transplantation and cellular therapy

Andermann TM, Fouladi F, Tamburini FB, Sahaf B, Tkachenko E, Greene C, Buckley MT, Brooks EF, Hedlin H, Arai S, Mackall CL, Miklos D, Negrin RS, Fodor AA, Rezvani AR, Bhatt AS.
PMID: 34274493
Transplant Cell Ther. 2021 Nov;27(11):932.e1-932.e11. doi: 10.1016/j.jtct.2021.07.009. Epub 2021 Jul 16.

Alterations of the gut microbiota after allogeneic hematopoietic cell transplantation (allo-HCT) are a key factor in the development of transplant-related complications such as graft-versus-host disease (GVHD). Interventions that preserve the gut microbiome hold promise to improve HCT-associated morbidity and...

Cite
Andermann TM, Fouladi F, Tamburini FB, et al. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplant Cell Ther. 2021;27(11):932.e1-932.e11doi: 10.1016/j.jtct.2021.07.009.
Andermann, T. M., Fouladi, F., Tamburini, F. B., Sahaf, B., Tkachenko, E., Greene, C., Buckley, M. T., Brooks, E. F., Hedlin, H., Arai, S., Mackall, C. L., Miklos, D., Negrin, R. S., Fodor, A. A., Rezvani, A. R., & Bhatt, A. S. (2021). A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplantation and cellular therapy, 27(11), 932.e1-932.e11. https://doi.org/10.1016/j.jtct.2021.07.009
Andermann, Tessa M, et al. "A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial." Transplantation and cellular therapy vol. 27,11 (2021): 932.e1-932.e11. doi: https://doi.org/10.1016/j.jtct.2021.07.009
Andermann TM, Fouladi F, Tamburini FB, Sahaf B, Tkachenko E, Greene C, Buckley MT, Brooks EF, Hedlin H, Arai S, Mackall CL, Miklos D, Negrin RS, Fodor AA, Rezvani AR, Bhatt AS. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplant Cell Ther. 2021 Nov;27(11):932.e1-932.e11. doi: 10.1016/j.jtct.2021.07.009. Epub 2021 Jul 16. PMID: 34274493; PMCID: PMC8556222.
Copy Download .nbib Format: NLM
A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing.

Genome research

Aevermann B, Zhang Y, Novotny M, Keshk M, Bakken T, Miller J, Hodge R, Lelieveldt B, Lein E, Scheuermann RH.
PMID: 34088715
Genome Res. 2021 Oct;31(10):1767-1780. doi: 10.1101/gr.275569.121. Epub 2021 Jun 04.

Single-cell genomics is rapidly advancing our knowledge of the diversity of cell phenotypes, including both cell types and cell states. Driven by single-cell/-nucleus RNA sequencing (scRNA-seq), comprehensive cell atlas projects characterizing a wide range of organisms and tissues are...

Cite
Aevermann B, Zhang Y, Novotny M, et al. A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing. Genome Res. 2021;31(10):1767-1780doi: 10.1101/gr.275569.121.
Aevermann, B., Zhang, Y., Novotny, M., Keshk, M., Bakken, T., Miller, J., Hodge, R., Lelieveldt, B., Lein, E., & Scheuermann, R. H. (2021). A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing. Genome research, 31(10), 1767-1780. https://doi.org/10.1101/gr.275569.121
Aevermann, Brian, et al. "A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing." Genome research vol. 31,10 (2021): 1767-1780. doi: https://doi.org/10.1101/gr.275569.121
Aevermann B, Zhang Y, Novotny M, Keshk M, Bakken T, Miller J, Hodge R, Lelieveldt B, Lein E, Scheuermann RH. A machine learning method for the discovery of minimum marker gene combinations for cell type identification from single-cell RNA sequencing. Genome Res. 2021 Oct;31(10):1767-1780. doi: 10.1101/gr.275569.121. Epub 2021 Jun 04. PMID: 34088715; PMCID: PMC8494219.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 143 entries